Thrombolysis by chemically modified coagulation factor Xa

BACKGROUND: Enzymatic thrombolysis carries the risk of hemorrhage and re-occlusion must be evaded by co-administration with an anticoagulant. Toward further improving these shortcomings, we report a novel dual-functioning molecule, Xai-K, which is both a non-enzymatic thrombolytic agent and an antic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thromb Haemost
Autores principales: Pryzdial, E. L. G., Meixner, S. C., Talbot, K., Eltringham-Smith, L. J., Baylis, J. R., Lee, F. M. H., Kastrup, C. J., Sheffield, W. P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576980/
https://ncbi.nlm.nih.gov/pubmed/27359348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13402
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares